BRIEF published on 04/23/2025 at 09:10, 1 year 4 months ago BioNxt Solutions Advances in MS Treatment Study Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study
PRESS RELEASE published on 04/23/2025 at 09:05, 1 year 4 months ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS BioNxt Solutions Inc. reports advanced preparation for human bioequivalence study of BNT23001, a novel sublingual thin-film Cladribine formulation for Multiple Sclerosis treatment BioNxt Solutions Inc. Multiple Sclerosis Treatment Sublingual Thin-Film BNT23001 Human Bioequivalence Study
BRIEF published on 03/15/2025 at 00:05, 1 year 6 months ago BioNxt Solutions Closes Final Tranche of Convertible Debenture Offering Private Placement Convertible Debenture Warrants Financing BioNxt Solutions
PRESS RELEASE published on 03/15/2025 at 00:00, 1 year 6 months ago BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement BioNxt Solutions Inc. completes final tranche of convertible debenture Offering for $900,000. Funds to be used for product dev, IP, debt repayment, and working capital Private Placement Convertible Debenture Healthcare BioNxt Solutions Inc. Drug Delivery Technologies
BRIEF published on 03/01/2025 at 01:40, 1 year 6 months ago BioNxt Solutions Secures $1.6 Million in Convertible Debenture Private Placement Private Placement Convertible Debenture Investment BioNxt Solutions Proceeds Utilization
PRESS RELEASE published on 03/01/2025 at 01:35, 1 year 6 months ago BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement BioNxt Solutions Inc. closes first tranche of convertible debenture units Offering, raising $1.6M. Proceeds for product development, IP filings, debt repayment, and working capital Private Placement BioNxt Solutions Inc. Intellectual Property Product Development Convertible Debenture Units
BRIEF published on 02/24/2025 at 15:05, 1 year 6 months ago BioNxt Solutions Launches Debenture Unit Financing Private Placement Regulatory Approvals Convertible Securities Debenture Units Compensation Warrants
PRESS RELEASE published on 02/24/2025 at 15:00, 1 year 6 months ago BioNxt Solutions Announces Debenture Unit Financing BioNxt Solutions Inc. announces a non-brokered private placement of debenture units and Finders Warrants, expecting gross proceeds of up to $2,500,000, subject to regulatory approvals Private Placement BioNxt Solutions Inc. Regulatory Approvals Debenture Units Finders Warrants
BRIEF published on 02/22/2025 at 01:40, 1 year 6 months ago BioNxt Solutions Inc. Clarifies Promotional Activity Agreements Investor Relations German Market BioNxt Solutions Promotional Activities Option Plan
PRESS RELEASE published on 02/22/2025 at 01:35, 1 year 6 months ago Clarification of Promotional Activities BioNxt Solutions Inc. provides a clarification on engaging Apaton Finance GmbH and Cayo Ventures GmbH for investor relations services in Germany and Switzerland Investor Relations Services BioNxt Solutions Inc. Apaton Finance GmbH Cayo Ventures GmbH German Translations
Published on 09/15/2026 at 05:00, 2 hours 18 minutes ago Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
Published on 09/15/2026 at 04:00, 3 hours 18 minutes ago Storm Closes Oversubscribed $3.2M Private Placement
Published on 09/15/2026 at 02:50, 4 hours 28 minutes ago RJK Explorations Ltd. Announces Closing of Previously Upsized Private Placement for Gross Proceeds of $150,000
Published on 09/14/2026 at 23:00, 8 hours 18 minutes ago AI/ML Innovations Inc. Closes Final Tranche of Private Placement
Published on 09/15/2026 at 07:02, 16 minutes ago SMG acquires 1.0% of its own shares in Mobiliar secondary placement
Published on 09/15/2026 at 07:00, 18 minutes ago Centiel signs agreement to acquire new production facility to support next phase of growth
Published on 09/15/2026 at 07:00, 18 minutes ago Sensirion announces global availability of the SFA40 formaldehyde sensor for indoor air quality applications
Published on 09/15/2026 at 06:05, 1 hour 13 minutes ago EUCLYD Raises Over €200 Million to Break the AI Efficiency Wall
Published on 09/15/2026 at 07:00, 18 minutes ago AXA announces its 2027-2029 strategy and financial targets
Published on 09/14/2026 at 18:21, 12 hours 57 minutes ago Reporting on share buyback transactions carried out between September 7 and September 10, 2026
Published on 09/14/2026 at 17:35, 13 hours 43 minutes ago Disclosure of transactions in own shares from September 7 to September 11, 2026
Published on 09/14/2026 at 16:15, 15 hours 3 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of August 31, 2026
